Key statistics · As on 15 Nov 2026
Market cap
BDT 1,692.600 mn
Free float market cap
BDT 763.589 mn
NAV per share
BDT 15.48
P/E (audited)
—
Day's value
BDT 6.70 mn
Day's volume
541,479
Day's trades
334
Volume Weighted Average Price (VWAP)
BDT 12.40
Opening price
BDT 12.40
Adjusted Opening Price
BDT 12.40
Yesterday's closing price
BDT 12.40
Closing price
—
Last Update
1:00 PM
Day's range
Current BDT 12.60
BDT 12.10BDT 12.60
52-week range
Current BDT 12.60
BDT 7.60BDT 18.00
Basics
- Listing year
- 2018
- Authorized Capital (mn)
- BDT 1,500
- Paid-up capital
- BDT 1,365.00 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 136,500,000
- Market Lot
- 1
Shareholding pattern
as on Jun 30, 2025 (year ended)
as on Sep 30, 2026
as on Oct 31, 2026
Sponsor / Director
45.21%
45.15%
45.15%
Government
0.00%
0.00%
0.00%
Institution
16.84%
16.08%
16.59%
Foreign
0.01%
0.01%
0.01%
Public
37.94%
38.76%
38.25%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- House # 65, Road # 8/A (New), Dhanmondi, Dhaka-1209.
- Factory Address
- Joykrishnapur, Main Road, Maijdee Court, Noakhali.
- Contact Phone
- +88-02-55000692, +88-02-55000952
- Fax
- +88-02-55000693
- share@silvapharma.com
- Company Secretary Name
- Md. Iqbal Hossain
- Company Secretary Cell No.
- 01711891686
- Company Secretary Telephone No.
- +88-02-9146009-205
- Company Secretary E-mail
- hossainiqbal.md123@gmail.com
- Website
- www.silvapharma.com
- Loan status
- Short-term: BDT 28.22 mn · Long-term: BDT 0 mn
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 30-12-2025
- Year-end
- June
Details of Financial StatementAnnual Reports – Silva Pharmaceuticals Ltd.
Price Sensitive Informationhttp://Price Sensitive Information – Silva Pharmaceuticals Ltd.